<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01094145</url>
  </required_header>
  <id_info>
    <org_study_id>UK-09157</org_study_id>
    <nct_id>NCT01094145</nct_id>
  </id_info>
  <brief_title>Deep Brain Stimulation (DBS) of the Nucleus Basalis Meynert (NBM) to Treat Cognitive Deficits in Light to Moderate Alzheimer's Disease</brief_title>
  <acronym>MeynD-DBS</acronym>
  <official_title>Deep Brain Stimulation of the Nucleus Basalis Meynert to Treat Cognitive Deficits in Light to Moderate Alzheimer's Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Cologne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Cologne</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In the study at hand, six patients with light to moderate Alzheimer's disease will be
      enrolled and implanted with bilateral electrodes in the nucleus basalis Meynert.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In the study at hand, six patients with light to moderate Alzheimer's disease will be
      enrolled and implanted with bilateral electrodes in the nucleus basalis Meynert. The
      stereotactic implantation of the electrodes will be guided by computerized tomography (CT)
      and magnetic resonance tomography (MRT).

      Basically, even though deep brain stimulation is an invasive method, there are only few side
      effects. Surgical risks correspond with the risk of DBS in morbus Parkinson or other movement
      disorders (0,4-6%).

      After the baseline examination, the patients will be implanted with the electrodes;
      accordingly all follow-ups are accomplished postoperative. From the second week after the
      operation, the conventional stimulation takes place as a doubleblind, randomized change
      between ON and OFF periods. Modifications of the stimulation parameter to obtain the best
      possible result are possible.

      Throughout the one-year observation-period, the patients will be followed closely to monitor
      the effects of DBS on their cognitive abilities, psychopathological well being, the quality
      of life, praxie and nutritional condition using standardized neurological and psychiatric
      rating scales.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2010</start_date>
  <completion_date type="Actual">January 2013</completion_date>
  <primary_completion_date type="Actual">January 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>cognitive improvement</measure>
    <time_frame>one- year</time_frame>
    <description>improving cognitive outcome parameters assessed by a series of standardized neuropsychological tests</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>determination of the optimal stimulation parameter</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">6</enrollment>
  <condition>Alzheimer Disease</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Stimulator setting is OFF</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Deep Brain Stimulation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Stimulator setting is ON</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Deep brain stimulation</intervention_name>
    <description>DBS in the Nucleus basalis Meynert</description>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_label>Deep Brain Stimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  German speaking male/female subjects

          -  age:60-80

          -  AD assessed by DSM-IV, ICD-10 and NINCDS-ADRDA-Scale

          -  no Lewy-Body-dementia or other form of dementia

          -  MMST &gt;18 and &lt;26

          -  stable psychopharmacological medication

          -  no psychotic symptoms, no suicidal tendency

          -  education for at least 8 years

          -  written informed consent of the patient

          -  consent of at least two family members

          -  no contraindication regarding PET-examination

          -  no contraindication regarding anesthesia or stereotactic operation

        Exclusion Criteria:

          -  legal accommodation

          -  clinical co-morbidity

          -  contraindication of MRT examination

          -  psychotic symptoms last six months

          -  aggressive behavior or suicidal tendency

          -  verbal IQ &lt;85

          -  stereotactic operation in previous history

          -  neoplastic neurological diseases

          -  serious organic disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Volker Sturm, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Cologne</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jens Kuhn, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Cologne</affiliation>
  </overall_official>
  <overall_official>
    <last_name>H. J. Freund, Prof. Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stellvertretender Leiter der Klinischen Prüfung Institut für Neurowissenschaften und Medizin (INM-7) Forschungszentrum Jülich</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Uni-Klinik Köln AöR</name>
      <address>
        <city>Cologne</city>
        <state>North Rhine Westphalia</state>
        <zip>50924</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>June 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 25, 2010</study_first_submitted>
  <study_first_submitted_qc>March 25, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 26, 2010</study_first_posted>
  <last_update_submitted>June 6, 2013</last_update_submitted>
  <last_update_submitted_qc>June 6, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 7, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Cologne</investigator_affiliation>
    <investigator_full_name>Jens Kuhn</investigator_full_name>
    <investigator_title>Prof. Dr. Jens Kuhn</investigator_title>
  </responsible_party>
  <keyword>(light to moderate)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alzheimer Disease</mesh_term>
    <mesh_term>Cognition Disorders</mesh_term>
    <mesh_term>Cognitive Dysfunction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

